Currently, there are 144.39M common shares owned by the public and among those 143.63M shares have been available to trade.
The company’s stock has a 5-day price change of 21.35% and -13.50% over the past three months. DAN shares are trading -34.63% year to date (YTD), with the 12-month market performance down to -26.03% lower. It has a 12-month low price of $7.58 and touched a high of $15.07 over the same period. DAN has an average intraday trading volume of 1.90 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 14.45%, -1.41%, and -17.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Dana Inc (NYSE: DAN) shares accounts for 89.94% of the company’s 144.39M shares outstanding.
It has a market capitalization of $1.38B and a beta (3y monthly) value of 2.32. The earnings-per-share (ttm) stands at -$0.11. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.30% over the week and 5.09% over the month.
Earnings per share for the fiscal year are expected to increase by 1.44%, and 34.12% over the next financial year. EPS should grow at an annualized rate of 8.56% over the next five years, compared to -38.20% over the past 5-year period.
Looking at the support for the DAN, a number of firms have released research notes about the stock. Wells Fargo stated their Underweight rating for the stock in a research note on September 20, 2024, with the firm’s price target at $13-$9. Deutsche Bank coverage for the Dana Inc (DAN) stock in a research note released on September 10, 2024 offered a Hold rating with a price target of $12. Wolfe Research was of a view on September 05, 2024 that the stock is Peer Perform, while UBS gave the stock Neutral rating on September 13, 2023, issuing a price target of $17. Barclays on their part issued Equal Weight rating on February 15, 2023.
